Healthcare Enterprise Group PLC
06 May 2005


Healthcare Enterprise Group PLC


Unique new Ebiox product passes tests for $300m market


Ebiox Limited ("Ebiox"), the wholly owned subsidiary of Healthcare Enterprise
Group PLC ("HCEG"), is extending its product offering with the development of a
new endoscope disinfectant having passed the required efficacy tests for the
$300 million high-level disinfectant market.


The tests proved that the new disinfectant kills tuberculosis in under five
minutes and harmful spores in under two minutes, outperforming the two key
requirements for high level disinfectants, laid down by regulatory and clinical
bodies worldwide. Continued development is planned over the next 12 months to
obtain worldwide registration. It is anticipated the product will be launched in
2006.


According to Frost & Sullivan, the research group, the global market for high
level endoscope disinfectants is worth an estimated $300 million and is growing
at 5% per annum.


The development of a new high-level disinfectant for endoscopes completes the
Ebiox range of instrument decontamination products.  Ebiox also markets a
surgical instrument cleaning range under the brand name Ultra, which has proven
more effective at cleaning instruments than existing detergents.


Stuart Bruck, Executive Chairman, Healthcare Enterprise Group PLC, commented:


"This unique new product will allow us to tackle disinfection of rigid and
flexible endoscopes in a completely different way.  We are confident that this
new decontamination technology will have a sizeable impact because of the
product's ability to remove harmful organic material, which existing
disinfectants in the market fail to do."

                                                                      6 May 2005

Enquiries:


Healthcare Enterprise Group (Financial)                            020 7351 7500
John Bradshaw, Group Finance Director

Healthcare Enterprise Group (Technical)                             01925 898236
Lorna Green, Director of Marketing

College Hill                                                       020 7457 2020
Corinna Dorward/Adrian Duffield


Notes


Healthcare Enterprise Group PLC


HCEG is quoted on the UK AIM stock market with its head office in London.   HCEG
is a business engaged in medical product distribution, occupational health,
first aid and medical consultancy markets.  These businesses underpin a range of
innovative medical devices, which will be introduced to the market via HCEG's
own distribution network on an international basis.







                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NRADELFBEEBEBBZ